Justin Gainor
0000-0001-8697-4081
4 papers found
Refreshing results…
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Performance status and end‐of‐life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
Missing publications? Search for publications with a matching author name.